ÍøºìºÚÁÏ

Bladder cancer is the 8th most common cancer in the ÍøºìºÚÁÏ Cancer Center catchment area and the 7th most common cancer presenting to UFÍøºìºÚÁÏ. Most newly diagnosed cases are stage I bladder cancer, which is defined by having no deep muscle…

Investigator

Paul L Crispen

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as…

Investigator

Paul L Crispen

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All